Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility? [electronic resource]
- Pathogens and disease Mar 2017
Publication Type: Journal Article; Review
2049-632X
10.1093/femspd/ftx025 doi
Animals Antigens, Bacterial--immunology Cost-Benefit Analysis Cross Reactions--immunology Humans Immunization Meningococcal Infections--epidemiology Meningococcal Vaccines--immunology Neisseria meningitidis--classification Outcome Assessment, Health Care Population Surveillance Prognosis